Updated:
GFR PHARMACEUTICALS INC
GFR PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001096294, and its reported industry...
Overview
GFR PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001096294, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2013-03-29, it reported annual revenue of USD 4,271,794; net income of USD 1,277,175; total assets of USD 12,166,364 for the fiscal period ended 2012-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- GFR PHARMACEUTICALS INC
- Former names in filing history
- LAREDO INVESTMENT CORP (1999-11-05 to 2004-08-09)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Maple Ridge, Canada
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 0001096294
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2012USD | $4.3M | $1.3M | $12.2M | $564,548 | $1.2M | |
| FY2011USD | $4.7M | $2.0M | $12.3M | $460,883 | $480,961 |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-Q | FORM 10-Q | ||
| 10-K | FORM 10-K | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | Form 10-Q | ||
| 10-K | Form 10-K | ||
| 10-Q | Form 10-Q | ||
| 10-Q | Form 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research GFR PHARMACEUTICALS INC in Altss
Track this company’s investors, transactions and relationships in Altss.